LV
Livzon Pharmaceutical Group Inc.
LVZPF · OTC
$5.22 +0.00% (+$0.00)
Market Cap ¥40.7B
P/E Ratio 24.46x
Div. Yield 4.02%
ROE 11.95%
Bulios Fair Price
$2.68
48.7% downside
Trenutna cena
$5.22
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica LVZPF trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
6/9Valuation
61 /100
Fair EV/EBITDA 14.77x
P/S 3.81x
P/B 3.04x
Growth
32 /100
Declining Rev. growth 2.79%
FCF growth 11.46%
Book val. growth 0.05%
Profitability
93 /100
Strong Net margin 15.59%
Op. margin 20.24%
FCF margin 27.20%
Quality
53 /100
Average ROE 11.95%
ROA 7.05%
Asset turnover 0.45x
Debt
96 /100
Low Current ratio 1.55x
Int. coverage 45.56x
Net debt/EBITDA -1.26x
Stability
78 /100
Stable Rev. volatility 1.90%
EPS volatility 3.34%
Profitable years 6
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o LVZPF
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Daping Liu
Employees
8,878
Headquarters
Zhuhai
Prihajajoči dogodki
27 OKT.
Earnings
Upcoming earnings report